mbiomics raised €12M in a Series A round in Apr 2026. The company is based in Munich, Germany. Investors in the round: Bayern Kapital, MIG Fonds. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
